Scandinavian ChemoTech and the India-Sweden Healthcare Innovation Centre celebrate the start of the clinical trial at AIIMS Jodhpur
Last week managers from both ChemoTech, the India-Sweden Healthcare Innovation Centre and Business Sweden were present during the official opening of the TSE Trial at All India Institute of Medical Sciences (AIIMS) in Jodhpur.The Investigator Initiated Trial that today officially was opened, at AIIMS Jodhpur, is designed to collect data from 30 patients with Head & Neck (H&N) cancer. The trial’s primary endpoint is to document the overall tumour control, after TSE therapy, in difficult-to-treat advanced H&N cancer patients. An even more important endpoint of the trial is to explore the